...injections.TARGETSPF4 (CXCL4) – Platelet factor 4tPA – Tissue plasminogen activator Sandi...

...its facility to manufacture tissue  plasminogen activator (tPA...
...change the name of the company to tPA...
...Bugos interview. “Tom, if we don’t have tPA...

...in stroke but one that’s eluded development in any indication. Unlike SOC alteplase, a recombinant tissue plasminogen activator (tPA)...
...the interaction between nerinetide and tPA by giving the two drugs sequentially, first nerinetide, then tPA...
...ND2 - NADH dehydrogenase subunit 2 PSD95 (DLG4) - Discs large homolog 4 tPA - Tissue plasminogen activator...

...He also proposed designing CAR T cells to dissolve blood clots by making them express TPA...

...where Shionogi retains rights. The drug is approved as Xofluza in Japan. Alteplase is a tissue plasminogen activator...

...from FDA. ALX-051 is in development for bleeding disorders with antiplasmin and antitissue plasminogen activator (tPA...

...where Shionogi retains rights. The drug is approved as Xofluza in Japan. Alteplase is a tissue plasminogen activator...
...a unit of Roche (SIX:ROG; OTCQX:RHHBY). Alicia Parker Actilyse, Actilyse Cathflo, Activacin, Activase, Cathflo Activase, GRTPA, alteplase (Tissue plasminogen activator (tPA)) Xofluza...

...with either therapy alone. In a microembolic mouse model of ischemic stroke, the inhibitor plus tissue plasminogen activator (tPA)...
...either agent alone. Next steps could include testing the C3d deposition inhibitor in combination with tPA...

...in 110 patients with moderate to severe acute ischemic stroke who were treated with IV tissue plasminogen activator (tPA)...

...the answer is no. On Dec. 5, Rebecca Gardner presented data from the Phase I/II PLAT-02...